Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2013 4
2014 3
2015 3
2016 4
2017 7
2018 6
2019 6
2020 2
2021 1
2022 2
2023 2
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Male breast cancer: a disease distinct from female breast cancer.
Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES, Cardoso F. Gucalp A, et al. Breast Cancer Res Treat. 2019 Jan;173(1):37-48. doi: 10.1007/s10549-018-4921-9. Epub 2018 Sep 28. Breast Cancer Res Treat. 2019. PMID: 30267249 Free PMC article. Review.
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group. Tsai CJ, et al. Lancet. 2024 Jan 13;403(10422):171-182. doi: 10.1016/S0140-6736(23)01857-3. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104577 Free PMC article. Clinical Trial.
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Scott JM, Lee J, Herndon JE, Michalski MG, Lee CP, O'Brien KA, Sasso JP, Yu AF, Rowed KA, Bromberg JF, Traina TA, Gucalp A, Sanford RA, Gajria D, Modi S, Comen EA, D'Andrea G, Blinder VS, Eves ND, Peppercorn JM, Moskowitz CS, Dang CT, Jones LW. Scott JM, et al. Among authors: gucalp a. Eur Heart J. 2023 Dec 7;44(46):4878-4889. doi: 10.1093/eurheartj/ehad085. Eur Heart J. 2023. PMID: 36806405 Free PMC article. Clinical Trial.
The Androgen Receptor: Is It a Promising Target?
Gucalp A, Traina TA. Gucalp A, et al. Ann Surg Oncol. 2017 Oct;24(10):2876-2880. doi: 10.1245/s10434-017-5961-9. Epub 2017 Aug 1. Ann Surg Oncol. 2017. PMID: 28766215 Review.
Menopause is a determinant of breast adipose inflammation.
Iyengar NM, Morris PG, Zhou XK, Gucalp A, Giri D, Harbus MD, Falcone DJ, Krasne MD, Vahdat LT, Subbaramaiah K, Morrow M, Hudis CA, Dannenberg AJ. Iyengar NM, et al. Among authors: gucalp a. Cancer Prev Res (Phila). 2015 May;8(5):349-58. doi: 10.1158/1940-6207.CAPR-14-0243. Epub 2015 Feb 26. Cancer Prev Res (Phila). 2015. PMID: 25720743 Free PMC article.
Advances in managing breast cancer: a clinical update.
Gucalp A, Gupta GP, Pilewskie ML, Sutton EJ, Norton L. Gucalp A, et al. F1000Prime Rep. 2014 Aug 1;6:66. doi: 10.12703/P6-66. eCollection 2014. F1000Prime Rep. 2014. PMID: 25165565 Free PMC article. Review.
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Ho AY, Barker CA, Arnold BB, Powell SN, Hu ZI, Gucalp A, Lebron-Zapata L, Wen HY, Kallman C, D'Agnolo A, Zhang Z, Flynn J, Dunn SA, McArthur HL. Ho AY, et al. Among authors: gucalp a. Cancer. 2020 Feb 15;126(4):850-860. doi: 10.1002/cncr.32599. Epub 2019 Nov 20. Cancer. 2020. PMID: 31747077 Free article. Clinical Trial.
41 results